GlaxoSmithKline | Fremdkapital



Loan Capital Veränderung Datum
AbbVie USD 64.53B 4.19B 2025-03
Alcon AG USD 4.6B 58M 2025-03
Almirall EUR 365.88M 24.38M 2025-06
Amgen USD 53.76B 253M 2025-06
argenx SE 35.57M 32.76M 2025-06
AstraZeneca USD 25.99B 1.9B 2025-06
Bayer EUR 31.71B 3.31B 2025-06
Biogen USD 6.28B 1.74B 2025-06
Bristol-Myers Squibb USD 44.47B 1.69B 2025-06
Eli Lilly USD 34.18B 319.4M 2025-06
Fresenius EUR 9.31B 2.08B 2025-06
Fresenius Medical Care EUR 6.33B 3.18B 2025-06
Galapagos EUR 6.05M 1.74M 2025-06
Genmab DKK 129M 808M 2025-03
Gilead Sciences USD 22.14B 6M 2025-06
GlaxoSmithKline GBP 15.3B 1.17B 2025-06
Glaxosmithkline GBP 14.64B 1.39B 2024-12
GRIFOLS EUR 7.45B 1.94B 2025-06
Hikma Pharmaceutical USD 607M 454M 2024-12
Lonza CHF 4.24B 602M 2024-12
Merck EUR 6.3B 665M 2025-06
Merck USD 33.97B 484M 2025-06
Novartis USD 24.06B 2.4B 2025-06
Novo Nordisk 87.3B 9.01B 2025-06
Orion EUR 136M 154.8M 2025-06
Pfizer USD 57.5B 137M 2025-06
Philips EUR 7.18B 126M 2025-06
Recordati EUR 2.09B 37.29M 2025-06
Regeneron Pharmaceuticals USD 1.99B 719.7M 2025-06
Roche Holding CHF 32.1B 1.94B 2024-12
Sanofi 13.2B 211M 2025-06
Smith & Nephew USD 3.3B 39M 2025-06
UCB EUR 2.96B 21M 2024-12


GlaxoSmithKline Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.